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Introduction
Providing prisoners access to condoms is
controversial. To some it seems hypocritical
– why would we give prisoners condoms
when it’s illegal to have sex in jail and prison
– and to others it seems like common sense,
unless we pretend to ignore the fact that
some sexual activity takes place in jails and
prison. There are clearly pros and cons and
unusual challenges to adopting a harm
reduction strategy in a law and order envi-
ronment.
On October 15, 2007, California Governor
Arnold Schwarzenegger vetoed the latest
“prison condom bill” to hit his desk. But this
time he directed the California Department
of Corrections and Rehabilitation to deter-
mine the “risk and viability of such a pro-
gram” by establishing a pilot program. What
follows is a review of the prisoner condom
access programs in two correctional facilities
– one in Los Angeles and one in San
Francisco – administered by the Center for
Health Justice, a community-based non-
profit organization focused on HIV and incar-
ceration, and on-going research on those
programs. This article is a written version of
a presentation given at the National
Convention on Correctional Health Care in
Nashville on October 17, 2007.
Condom Access for Prisoners: Pros and
Cons
There are serious concerns about providing
prisoners with condoms. Introducing any-
thing new into the security environment pro-
vides prisoners with an additional potential
tool for conducting illegal activities including
secreting contraband and assaulting staff
with bodily fluids or excrement (called
“gassing” in California). Further, in a rule-
based environment it can be considered
hypocritical to tell prisoners it’s illegal to
engage in sexual activity and then provide
the means to “safely” engage in that activity.
From this viewpoint it sends the wrong mes-
sage, and could be used by assailants to
prevent evidence of sexual assault from
remaining.
There are reasons why provision of con-
doms to prisoners might be a good idea.
Even though it is illegal to have sex in jail or
prison, that rule cannot be perfectly enforced
in the many overcrowded and understaffed
institutions in this country. Both scientific evi-
dence and popular media point to the fact
that sexual activity takes place behind bars.
Last year the Centers for Disease Control
and Prevention (CDC) published in the
Morbidity and Mortality Reports (MMWR) a
study that documented seroconversion dur-
ing incarceration.1 Those who became HIV-
infected were 8 to 10 times as likely to report
engaging in male-to-male sexual activity
while in prison than those who did not.
The prevalence of known HIV among pris-
oners is extremely high: the rate of HIV
infection among prisoners is 5 to 7 times that
of the general population.2,3 The very
behaviors that put people at risk for HIV
infection – injection drug use and sex work –
are also behaviors that can lead to incarcer-
ation. In the U.S., approximately one in four
persons with HIV infection passes through a
jail or prison each year – and many of those
do not know they are infected.4 Therefore, a
considerable number of HIV-infected prison-
ers may not know they are HIV-infected and
as such unwittingly may transmit their infec-
tion to others.
Where are condoms provided to
inmates?
Condoms are provided to prisoners in coun-
ty jails in Los Angeles, San Francisco,
Philadelphia, Washington, D.C. and New
York and in the state prisons in Vermont and
Mississippi. The manner in which condoms
are made available varies widely among
these facilities. In Los Angeles, the Center
for Health Justice distributes free condoms
to a segregated gay male population only,
one condom per week per inmate, a limit
imposed by the Los Angeles Sheriff’s
Department. San Francisco’s Forensic AIDS
Project (part of the Department of Public
Health) distributes condoms upon request
through its public health nurses in one-on-
one health counseling sessions, one per
person, per request, and upon release.
Earlier this year the Center for Health
Justice in San Francisco installed a condom
dispensing machine – a vending machine
set to require no payment – in a gym to
which 800 prisoners have access. About 70
condoms per week are taken from the
machine.
In Washington, D.C., prisoners in the D.C.
jail system have access to free condoms
during health education classes, voluntary
HIV pretest or posttest counseling, or upon
request to members of the health care staff.
The jail’s health educator and staff of a com-
munity-based AIDS service provider distrib-
ute about 200 condoms to prisoners each
month. In Philadelphia, prisoners can get
condoms from the medical services depart-
ment or through the commissary. These
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Dear Correctional Colleagues,
There are few more controversial issues in correctional health than the distribution of condoms
in prisons and jails. The arguments on both sides are well known and have been described in
the pages of IDCR in the past. But, while condoms remain unavailable to most of those who
are incarcerated, there are a few facilities where they can be found. In Mississippi and Vermont
state prisoners are provided condoms, and they are also made available in several jails in parts
of the country. These condom distribution programs have continued quietly, with many in our
field unaware of their existence.
In California, that condoms are distributed to some jailed inmates is now no secret. A recent
veto of a bill to make condoms available to prisoners by that state’s governor and his subse-
quent directive to study the feasibility of condoms in correctional settings placed the issue
squarely in the spotlight. Not a state to shy from social experimentation, California has actual-
ly had condom programs in place in certain jails for years. The experience of these facilities
provides valuable lessons that can inform future HIV/STD prevention policies in our nation’s
correctional facilities.
In this issue Mary Sylla, JD, MPH, Director of Policy & Advocacy Center for Health Justice in
California provides a brief overview of the potential merits and disadvantages of the provision
of condoms in jails and prisons and describes two jail-based condom programs in her state.
Her report is balanced and informative and makes clear that in these facilities condoms have
not been found to be dangerous but they were no prevention panacea as inmates often did not
use them – hardly a surprise to anyone trying to get people in the free world to adopt condoms
as part of safer sex.
Also in this issue Leah Holmes from Rhode Island provides an update on Project Bridge, an
innovative program of case management that spans the periods before and after release.
Accompanying her report is a description of a study of a similar program we have launched in
North Carolina. These programs are both successful and serve as important examples of the
value of continuity of care in the reintegration of the HIV-infected into their communities.
Your thoughts regarding what you read in IDCR are important to us. Email your comments to
me at wohl@med.unc.edu. Please indicate if you would like to have your comment posted on
our letters to the editor section of the IDCR website.
David A. Wohl, MD
Associate Professor of Medicine
Division of Infectious Diseases
AIDS Clinical Research Unit
The University of North Carolina - Chapel Hill
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methods of providing prisoners access to
condoms vary, and most reach only a small
subset of the prisoner population in the jail
and prison systems in which they operate.
Two pilot programs of condom distribu-
tion in California
The Los Angeles County Jail Model
The Los Angeles condom access program
was the result of a unique set of circum-
stances: a new Custody Chief – who had
just been promoted from Medical Services –
approached the Center for Health Justice
about the possibility of designing a program
that could provide gay male prisoners in dor-
mitory-style housing units access to con-
doms without involving custody staff or time.
The program today exists as it did when
implemented: once a week a health educa-
tor from the Center for Health Justice goes
in to each dorm, provides a brief, interactive
HIV education session, the rules of the pro-
gram (including that sex is still illegal in jail
under California law and that the condoms
are not to leave the dorm or they will be con-
sidered contraband) and hands one condom
to each prisoner who lines up to receive one.
Although the average has changed over
time, the Center for Health Justice currently
distributes about 120 condoms per week to
the 300+ prisoners in this unit.
To evaluate this program, 101 of the approx-
imately 300 prisoners who live in the unit for
segregated gay males were asked a series
of questions through a computer-assisted
self-interview program. Although the formal
data analysis has not been completed, inter-
esting statistics compiled so far include that
93% of respondents were aware of the con-
dom program and 82% had received at least
one condom from the program. Fifty-three
percent of respondents reported anal sex
during the past 30 days – but despite access
to condoms, 75% of those who reported
anal sex during the past 30 days said it was
unprotected. The three top reasons for not
using condoms were: (1) my partner and I
are both HIV negative (or positive); (2) I ran
out of condoms; and (3) I don’t like the way
condoms feel. Information was gathered
about other methods of condom access:
66% preferred the current method of distrib-
ution; other methods of distribution that
would be to others who indicated Medical
(41%), Vending (10%), or Canteen (8%).
The results of this evaluation will be finalized
and published during the coming year, but
support the assertion that some risk-reduc-
tion is achieved in this population through
access to condoms.
The San Francisco County Jail Model
In San Francisco, the Center for AIDS
Prevention Studies and Dr. Olga Grinstead
are conducting research on a novel way to
provide prisoners access to condoms that
has been successful in other countries. As
mentioned earlier, in San Francisco, prison-
ers have had access to condoms since 1987
through the Forensic AIDS Project’s health
educators in one-on-one individual consulta-
tions. In the fall of 2006, the Center for
Health Justice, Dr. Grinstead and the
Forensic AIDS Project approached the
Sheriff of San Francisco about installing a
condom dispensing machine, in part
because of reports from Forensic AIDS
Project staff that the demographic charac-
teristics of the health educator seemed to
influence whether a prisoner being coun-
seled took a condom. The Center for Health
Justice sought to evaluate a more anony-
mous method of providing prisoners access
to condoms, as well as being less staff-
intensive.
The dispensing machine program and its
pilot feasibility are being conducted by the
Center for Health Justice in collaboration
with the Forensic AIDS Project. The
machine was installed in April 2007 in a gym
to which 800 prisoners have access every
week for their three hours of recreation.
Sheriff Michael Hennessey himself, to pro-
vide a large number of prisoners access to
it, suggested the precise location of the
machine. Prior to installing the machine,
brief written surveys were conducted with
prisoners to elicit baseline information about
their HIV status, knowledge of the existing
condom program and risk behavior.
Interviews were conducted with Sheriff’s
Department staff to assess attitudes about
condom access for prisoners and determine
potential security concerns. Center for
Health Justice staff also made presentations
to all deputy staff and prisoners affected by
the program before the machine was
installed. The same written survey and simi-
lar interviews were conducted after the
machine was operational for four months.
The machine itself is a low-profile tamper-
resistant unit, designed to withstand break-
inattempts. The machine dispenses con-
doms in a cellophane wrapped paper box.
Inside the box the condoms are enclosed in
another cellophane wrapper. The “Condom
Machine Rules” posted next to the machine
indicate that condoms are to be removed
from the box and carried only in the clear
wrapper, with the condom inside visible.
The Condom Machine Rules, in full, read:
During the study period the Center for
Health Justice successfully installed,
stocked and maintained the condom
machine. Data analyses of the pre- and
post-surveys and interviews are currently
underway. Preliminary data analyses indi-
cate that prisoner self-report of sexual activ-
ity did not increase during the study period;
in addition the custody staff have reported
no increase in reported sexual activity or any
other security problems related to increased
condom access. We have encountered few
operational problems, the most notable
falling on the staff restocking the machine:
the machine was difficult to open and close
for restocking and sometimes jammed. A
new model of machine has been purchased
to address these problems.
Evaluations of these two pilot programs are
currently being analyzed. In Los Angeles,
Charles R. Drew University’s Dr. Nina
Harawa and the Center for Health Justice
(with funding from the California HIV/AIDS
Research Program-funded Institute for
Community Health Research) are evaluating
the current Los Angeles County Sheriff’s
Department program to determine whether
the program is reducing sexual risk activity.
Conclusions: Condoms coming soon to
a facility near you?
While controversial, there is a trend toward
increased prisoner access to condoms. The
CDC now recommends that prison systems
with existing condom distribution programs
evaluate those programs, and those without
such programs consider the feasibility of
implementing condom distribution pro-
grams. Governor Schwarzenegger’s “friend-
ly” veto of legislation requiring prisoner
access to condoms may result in a pilot pro-
ject across the state. At the federal level,
Representative Barbara Lee’s JUSTICE Act
of 2007 (H.R. 178), modeled on the
California bill, requires federal prisoners to
have access to condoms. Even where leg-
islation is not pending, jails and prisons are
considering the issue.
Regardless, programs that involve correc-
tions cannot be successful without the sup-
port of the administration of corrections sys-
tems. The best circumstances for risk-
reduction involve input at the development
stage, and any success these programs
have is a credit to the professionalism of the
corrections staff in the facilities where they
exist.
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Take only one condom per visit to the
gym.
Immediately open condom package
and discard the external paper box and
cellophane wrapper.
Condoms enclosed in the clear sealed
plastic wrapper are not contraband.
Condoms remaining in the orange box
or removed from the clear sealed plas-
tic wrapper are contraband and will be
confiscated.
Having sex in jail is illegal under
California Penal Code § 286(e).
Failure to obey these rules will result in
discontinuation of this condom access
program.
4Continued on page 5
SPOTLIGHT I: PROJECT BRIDGE: A TRANSITIONAL CASE MANAGEMENT PROGRAM FOR HIV-
INFECTED MEN AND WOMEN
Leah Holmes, LICSW
Project Bridge
Principal Investigator and Project Director
The Miriam Hospital,
Providence, Rhode Island
Disclosures: None
Introduction
Project Bridge is an intensive case manage-
ment program for HIV-positive ex-offenders
at The Miriam Hospital in Providence, Rhode
Island. The program is located off-site from
the hospital in the neighborhood where a
majority of offenders lived before incarcera-
tion. The program staff consists of two mas-
ter’s level social workers who are responsible
for the overall management of each case and
two paraprofessional outreach workers who
locate missing clients and provide support to
access concrete services, such as food
stamps and housing applications. The social
worker meets with prospective clients from
30 to 60 days before release at the correc-
tional facility to identify the most pressing
needs facing the client. After release, they
provide supportive counseling, and coordi-
nate medical, legal, substance use, and men-
tal health treatment. The primary goal of the
program is to enhance continuity of medical
care through increasing social stability.
Attending to basic survival and social support
needs is fundamental to retaining ex-offend-
ers in medical care.
Program Overview
Client enrollment began in February 1997.
Since that time, we have learned several
lessons. The first lesson is the importance of
having the social worker attend medical visits
with the client. Clients rate this as the most
salient factor in keeping medical appoint-
ments and adhering to medications. They
welcome the emotional support and the
assistance in understanding medical terms
and directives. It facilitates in obtaining med-
ications, and assuring that comprehension of
dosing schedules, and requirements to pre-
pare for medical tests and procedures exist.
The second lesson is that clients need to be
in very close contact during the initial phase
of re-entry. We request that they either come
to the office or have telephone contact daily
for the first month. The outreach worker
assists them to access many service needs,
while the social worker creates a treatment
plan and provides supportive counseling.
Frequency of contact builds a working rela-
tionship and develops trust.
The third lesson is the importance of visiting
reincarcerated clients as quickly as possible
after their arrest. They are at a point of crisis
and change is most likely to occur when
usual coping strategies are ineffective.
Clients who have visits during reincarceration
are more strongly committed to the program
following re-release.
The final lesson is to tailor length of enroll-
ment to the client’s needs. A very small num-
ber of clients stabilize within six months.
Generally, these people were first-time
offenders and have intact social and financial
support in the community. Most clients
remain enrolled for 18 – 24 months and then
transfer to other providers for continuing ser-
vices.
Participant Demographics
Project Bridge’s most recent evaluation cov-
ered the period between 2003 and 2005.
Sixty-five participants enrolled in the study.
Participants were primarily male (66%) with
one being transgender. They were also pri-
marily heterosexual (82%). Race was nearly
even between African American (41%) and
White (42%) with the remainder Native
American or Other (6%) or more than one
race (5%). Hispanic ethnicity was reported by
14% and 6% were primarily Spanish speak-
ing. The attrition rate was 20%. One partici-
pant died, three moved out-of-state, two with-
drew from the study shortly after prison
release, and seven were re-incarcerated and
received sentences that exceeded six
months. It was at that time an SPNS funded
project began to find methods of outreach for
out-of-care or sporadic users of care. It
ended in 2006. Project Bridge has continued
as a Part B (formerly Title II) funded program.
The staffing has been reduced to one MSW
and one BA outreach worker.
Effectiveness of Medical Retention
In the first six months of enrollment, 98% of
the clients received medical care. In the final
six months of their enrollment, 100%
received medical care. The evaluation includ-
ed a chart review six months after clients
graduated from the program to see if there
was decay in the program effects. This
showed that 89% had continued to seek
medical care.
Future Steps
Project Bridge is continuing thanks to ongo-
ing Ryan White Part B funding provided by
the Rhode Island Department of Health. This
model can and should be tailored to other
facilities in other states. It can also be tailored
to other disease states. Drs. Peter Friedman
and Lynn Taylor have recently received a
National Institutes of Health (NIH) grant that
will use the Project Bridge model to provide
care for offenders with hepatitis C virus
(HCV) infection being released from incarcer-
ation. This will allow us to start offenders on
HCV treatment while incarcerated and con-
tinue therapy following community release.
Presently, offenders only receive this treat-
ment if they are serving a sentence with at
least a year remaining before release.
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SPOTLIGHT II: THE BRIGHT PROJECT: BRIDGES TO GOOD HEALTH AND TREATMENT FOR HIV-
INFECTED INDIVIDUALS BEING RELEASED FROM PRISON
David Alain Wohl, MD
Associate Professor of Medicine
Division of Infectious Diseases
AIDS Clinical Research Unit
The University of North Carolina- Chapel Hill
Disclosures: Speaker: Abbott Laboraties,
Gilead Sciences, Inc., Tibotec Therapeutics,
Roche Pharmaceuticals, Merck & Co.,
Boehringer-Ingelheim, Bristol-Myers Sqibb.
Introduction
The Bridges to Good Health and Treatment
(BRIGHT) Project began as a National
Institutes of Health (NIH)-supported clinical
trial that aimed to understand if an intensive
case management intervention that began
within the three months prior to state prison
release and continued for six months post-
release could increase access to HIV care
and services, and reduce recidivism and
enhance safe sex practices among HIV-
infected releasees in North Carolina. The trial
began in 2001 and enrolled 104 individuals
who were randomized to the intervention or
to standard discharge planning, which does
not include post-release activity. Preliminary
results indicate the intervention is successful
at increasing access to routine HIV care and
reducing risk of re-arrest. Based on these
findings, the BRIGHT intervention has now
been made a non-research service offered to
the majority of HIV-infected inmates facing
release.
Program Overview
The BRIGHT Program is a unique interven-
tion designed to improve the well-being of
HIV-infected prison releasees. The case
management approach used in the program
is based on the Strengths Model. This model
holds that all individuals have strengths,
desires, aspirations, interests, experience tal-
ents, knowledge, resiliency and ascribed
meaning. It is these that are the focus of a
healthy helping relationship, and not the con-
centration on weaknesses or deficits. The
work is done with participants within the con-
text of a collaborative and mutually enriching
and respectful partnership in order to identify,
secure and sustain a range or resources
(both external and internal) needed to live in
a normally interdependent manner in the
community. Unlike traditional case manage-
ment, the Strengths Model permits the partic-
ipant to be an active part of the decision-mak-
ing process rather than be passive or depen-
dent on others.
The BRIGHT case managers begin to work
with participants as soon as three months
prior to scheduled release, meeting with them
regularly to assess for strengths and devel-
oping a personal wellness plan together.
After release, the BRIGHT case manager will
work intensively along side the participant to
realize the plans established during incarcer-
ation, refining them as needed to confront
new goals and challenges. After six months,
the participant is slowly transitioned to com-
munity case management services. BRIGHT
case managers are permitted a maximum
case load of 15 participants as a heavier
case load would compromise the quality of
the intervention.
All HIV-infected inmates in North Carolina,
including the BRIGHT Program participants,
also receive discharge planning assistance
during their incarceration from North Carolina
Department of Corrections (NCDOC) HIV
Outreach Nurses. These nurses and the
5BRIGHT case managers work closely espe-
cially as release nears.
Accomplishments to Date
The program began as a clinical trial of 104
inmates. Preliminary results following the
release of the first 91 participants have been
previously presented at the 2006
International AIDS Society Conference in
Toronto. At the time of the analysis, 81% of
the participants were African-American, 26%
were women, median CD4 cell count was
350/mm3 and median viral load was 1,430
copies/mL; and 74% were taking antiretrovi-
ral medications. Ninety percent had a histo-
ry of substance abuse and at baseline, 51%
had major depression based on standardized
screening assessment with the CES-D.
At three months post-release, only 21% of
those receiving bridging case management
had not attended a routine HIV clinic visit
compared to 43% of those not receiving the
intervention (p=0.059). Similarly, emergency
room visits, a measure of inadequate access
to routine medical care, occurred in 28% of
those assigned to the case management ver-
sus 44% of the controls. Re-arrest rates for
those under case management are generally
half that of the controls. Final analyses of the
complete cohort are ongoing as the final on-
study visit occurred in September 2007. All
participants are followed for a year post
release.
Following the early success of this trial, the
investigative team sought and received fund-
ing from private foundations to continue the
program and expand access to the interven-
tion. During the trial three bridging case
managers were employed and worked with
participants returning to the three largest
metropolitan areas of North Carolina
(Raleigh-Durham, Greensboro-Winston-
Salem, Charlotte). With the expansion of the
program, BRIGHT is now in almost 30 coun-
ties statewide, including Asheville in the
western part of the state and rural areas well
outside of urban centers. Over 45 partici-
pants have now been enrolled in the post-
study program since February 2007 and six
case managers are administering the
BRIGHT intervention.
Future Steps
While the BRIGHT program continues
through the generosity of private funding
sources, other support will eventually need to
be identified to maintain the program.
Following the final analysis of the trial results,
support from governmental and other sus-
tainable sources will be sought. Meanwhile,
the program has established strong collabo-
rations with community AIDS Service
Organizations, training case managers within
these organizations in Strengths Model
based bridging case management. In a
unique arrangement the BRIGHT Program
clinically supervises these community case
mangers. The benefits of this program have
been evident to the staff and participants, as
well as community service providers. During
the next year, we will disseminate our instru-
ments, manuals and procedures so that oth-
ers can also develop and implement transi-
tional programs to identify and capitalize on
the strengths of HIV-infected releasees.
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SPOTLIGHT II: THE BRIGHT PROJECT:
(continued from page 4)
Center for Health Justice
http://healthjustice.net/
Community HIV/AIDS Mobilization Project
http://www.champnetwork.org/
CDC’s National HIV Testing Resource Website
http://www.hivtest.org/
CDC's Revised Recommendations for HIV Testing of Adults,
Adolescents, and Pregnant Women in Health-Care Settings
http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5514a1.htm
National HIV/AIDS Clinician’s Consultation Center
Warmline: National HIV Telephone Consultation Services
1-800-933-3413
PEPline: National Clincian’s Post-Exposure Prophylaxis Hotline
1-888-448-4911
Perinatal Hotline: National Perinatal HIV Consultation and Referral
Services
1-888-448-8765
Department of Health and Human Services
2006 Adult and Adolescent Antiretroviral Treatment Guidelines
http://www.aidsinfo.nih.gov/guidelines/
International AIDS Society-USA Panel
2006 Recommendations of the Treatment for Adult HIV Infection
http://jama.ama-assn.org/cgi/content/full/296/7/827
American Academy of HIV Medicine
http://www.aahivm.org/
CME-accredited web-stream of “Occupational & Non-Occupational
Post-Exposure Prophylaxis”
www.amc.edu/hivconference
Slides from the NCCHC Pre-conference Seminar
Infectious Diseases in Corrections: An Expert Panel
October 28, 2006
http://www.idcronline.org/archives.html
RESOURCES
IDCR-O-GRAM: PROPORTION OF HIV-INFECTED PARTICIPANTS RECEIVING ROUTINE HIV CARE FOLLOWING
PRISON RELEASE DURING THE BRIGHT STUDY – A RANDOMIZED CONTROLLED TRIAL OF BRIDGING CASE MAN-
AGEMENT VS. STANDARD DISCHARGE PLANNING
BCM (BRIGHT Case Management)
SOC (Standard Discharge Planning)
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National HIV Prevention
Conference
Atlanta, GA
December 2-5, 2007
Visit:http://www.2007nhpc.org
AIDS in Culture IV: Explorations
in the Cultural History of AIDS
Mexico City
December 9-13, 2007
Visit:www.aidsinculture.org
American Correctional
Association Winter Conference
Grapevine, TX
January 11-16, 2008
Visit:http://www.aca.org/conference
s/Winter08/
Conference on Retroviruses and
Opportunistic Infections (CROI)
Boston MA
February 3 - 6, 2008
Visit:http://www.retroconference.org/
2008/
2nd Annual Academic and Health
Policy Conference on
Correctional Health
Boston Marriott, Quincy, MA
March 27-28, 2008
Visit:http://www.umassmed.edu/Cor
rectional_Health_Conf/index.aspx
SAVE THE
DATES FDA Approves Raltegravir as First in New Class of
Antiretrovirals
The U.S. Food and Drug Administration approved the
use of raltegravir tablets in treating infections of HIV-1 in
treatment-experienced individuals. The approval of ralte-
gravir offers hope to individuals who have evidence of
resistance to other antiretroviral drugs and represents
one of a handful of new classes of antiretroviral drugs
that have been approved in recent months. Raltegravir,
which received a priority review by the FDA, is the first in
a new class of antiretroviral drugs, known as HIV inte-
grase strand transfer inhibitors that are designed to inter-
fere with the enzyme that HIV-1 needs to multiply.
Raltegravir was approved for use in treatment-experi-
enced patients after the review of data from two double-
blind, placebo-controlled studies in 699 HIV-1 infected
patients with a history of extensive antiretroviral treat-
ment and evidence of resistance to at least one anti-
retroviral drug. Individuals who received raltegravir in
combination with other antiretrovirals experienced lower
plasma HIV viral loads when compared to individuals
who received a placebo in combination with other anti-
retroviral drugs. This trial did not include the use of ralte-
gravir in persons less than sixteen years of age or in
pregnant women. Some of raltegravir’s most common
side-effects include diarrhea, nausea, and headache,
along with elevated levels of CPK.
U.S. Food and Drug Administration.
http://www.fda.gov/bbs/topics/NEWS/2007/NEW01726.
html.
Rapid Fibrosis Progression Among HIV/Hepatitis C
Virus Co-infected Adults
Between 15-30% of all HIV-infected individuals are also
co-infected with hepatitis C (HCV) and HCV-related liver
disease has grown to become a leading cause of death
among persons infected with HIV.
Recent studies have sought to examine possible links
between the use of HIV antiretroviral drugs and the pro-
gression of HCV-related liver disease. Some retrospec-
tive studies have found a lower prevalence of cirrhosis
and mortality in HCV-infected individuals who were
receiving antiretroviral treatment for HIV-infection. Other
studies have demonstrated an association between anti-
retroviral use and acute and chronic liver inflammation.
To examine the pace of fibrosis progression in HIV-HCV
co-infected patients and identify predictors of fibrosis
advancement, the medical records of 184 HIV/HCV co-
infected individuals from the Johns Hopkins University
HIV clinic cohort with at least two liver biopsies per-
formed between January 1998 and July 2006 were stud-
ied. The majority of patients were African American men
and past or active drug use was reported in 78% of all
patients.
Nearly a quarter of co-infected patients in this study had
evidence of significant fibrosis progression over a three-
year interval. Antiretroviral and HIV disease measures
were not associated with liver disease progression.
Moreover, this study did not find evidence of long-term
liver injury as a result of antiretroviral treatment. Only
elevated levels of serum AST (but not ALT) between
biopsies was shown to be an independent indicator of
liver-disease progression.
Rapid fibrosis progression among HIV/hepatitis C virus-
co-infected adults. Sulkowski, M. et al. AIDS.
2007;21:2209-2216.
ACLU’s Efforts Lead to More Equal Treatment of HIV-
Positive Prisoners in Alabama
After years of advocacy, the American Civil Liberties
Union (ACLU), Alabama state legislators, and the AIDS
service organization AIDS Alabama, have made head-
way with the Alabama Department of Corrections
(ADOC) to allow HIV-positive prisoners greater access
to educational programs, visitation, substance abuse
treatment programs, and religious services. These pro-
grams and services have historically been denied to HIV-
positive inmates. This decision comes after a letter from
the ACLU was sent to ADOC Commissioner Richard F.
Allen. The letter urged Commissioner Allen to put a stop
to the discriminating segregation policies at the ADOC.
Alabama remains the only state in the union to segre-
gate HIV-positive prisoners and deny them access to
programs and services available to the greater prisoner
population. Before the changes, HIV-positive inmates at
the Julia Tutwiler Prison for Women and the men’s
Limestone Correctional Facility were completely isolated
from the general population and given limited access to
family visits, library, work opportunities, other services
available to the general population. Since 1997, the
ACLU, and advocates for people living with HIV have
lobbied against these policies in two trials in the Eleventh
Circuit Court of Appeals and the Alabama Supreme
Court. The campaigns led to the release of a major
report by the Alabama’s Governor’s HIV Commission for
Children, Youth, and Adults, finding that there was over-
whelming evidence to suggest that the segregation poli-
cies had no public health or safety justification.
HIV-Positive Prisoners Receive More Equal Treatment
in Alabama After ACLU's Efforts. (11/1/2007).
http://www.aclu.org/prison/restrict/32510prs20071101.ht
ml
Trends in HIV Testing and Differences Between
Planned and Actual Testing in the United States,
2000-2005
Researchers at the Duke University Health Inequalities
Program recently conducted a pooled cross-sectional
analysis of data from the 2000-2005 National Health
Interview Surveys (NHIS) in order to examine longitudi-
nal trends in planned and actual HIV testing. The study,
which appeared in the Archives of Internal Medicine,
pooled data from six consecutive nationally representa-
tive cohorts of adults participating in the NHIS and exam-
ined the relationship between HIV testing rates and self-
reported risk of HIV. Researchers also focused on
understanding the relationship between planned and
actual testing, as well as how demographic characteris-
tics, HIV risk, and other health behaviors might impact
testing rates.
The researchers found that rates of HIV testing remained
low and relatively unchanged during the six year span of
this study’s data. Minority women had both the highest
rates of lifetime HIV tests and the highest rates for HIV
tests in the past twelve months. Conversely, white men
were found to have both the lowest rates of lifetime HIV
tests and the lowest rates for HIV tests in the past twelve
months. The study also reported both white and minority
women as having modest increases in lifetime HIV test-
ing rates. Over 60% of participants who reported a spe-
cific HIV risk factor or had high current risk had ever
been tested for HIV and more than twenty-percent of this
group reported having been tested for HIV in the past
year. Of all of the respondents who had previously been
tested for HIV, 23.7% had a reason for getting tested for
HIV, whereas 44.2% of tests had been administered as
a part of routine care. In addition, 20.9% of tests were
conducted to fulfill an insurance, marriage, immigration,
or military requirement. Also, more than one-sixth of HIV
tests were related to prenatal care.These findings are
significant as they demonstrate the effectiveness of
incorporating HIV testing into routine health care, as is
recommended by the Centers for Disease Control and
Prevention.
Trends in HIV Testing and Differences Between Planned
and Actual Testing in the United States, 2000-2005.
Ostermann, J. et al. Arch Intern Med. 2007;167:2128-
35.
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Objectives:
The learner will be able to describe the condom access programs in both the Los Angeles and San Francisco jails.
The learner will be able to summarize the elements and data related to Project Bridge in Rhode Island.
The learner will be able to explain the elements and data related to Project BRIGHT in North Carolina.
1. In the main article, which of the following was NOT cited as a reason
for providing condoms to prisoners?
A. Even though sex in prison is illegal, the rule cannot always be
enforced.
B. The prevalence of known HIV among prisoners is estimated is
five to seven times greater than that of the general population.
C. Condom access programs have proven to be very successful in
European correctional facilities.
D. In the US approximately one in four persons infected with HIV
infection pass through a correctional facility each year.
2. The Forensic AIDS Project’s health educators have distributed
condoms in San Francisco’s jails since 2005.
TRUE or FALSE
3. The preliminary data analyses of the condom dispensing machine
access program in the San Francisco jail indicate which of the
following?
A. Prisoners have been using the condoms as weapons.
B. Custody staff have reported no increase in reported sexual
activity or security problems related to the condom dispensing
machine access.
C. Prisoner self-report of sexual activity has stayed the same.
D. Both B and C
4. Commonalities between North Carolina’s BRIGHT Project and Rhode
Island’s Bridge Project include:
A. Clients begin intensive case management several months befor
their release date.
B. Clients maintain very close contact with their caseworkers during
the initial phase of re-entry.
C. The primary goal is to increase access to HIV care and services
and reduce recidivism.
D. All of the above.
5. Which program, the BRIGHT Project or Project Bridge utilizes the
Strengths Model in its approach to case management.
A. The Bright Project
B. Project Bridge
C. Both A and B
D. None of the above
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COURSE EVALUATION
I. Please evaluate this educational activity by checking the appropriate box:
Activity Evaluation
Faculty
Content
How well did this activity avoid com-
mercial bias and present content that
was fair and balanced?
What is the likelihood you will
change the way you practice based
on what you learned in this activity?
Overall, how would you rate
this activity?
Excellent Very Good Good Fair Poor
II. Course Objectives
Were the following overall course objectives met? At the conclusion of this presentation, are you able to:
III. Additional Questions
a. Suggested topics and/or speakers you would like for future activities.
b. Additional Comments
YES NO SOMEWHAT
YES NO SOMEWHAT
YES NO SOMEWHAT
The learner will be able to describe the condom access programs in both the Los Angeles and San
Francisco jails.
The learner will be able to summarize the elements and data related to Project Bridge in Rhode Island.
The learner will be able to explain the elements and data related to Project BRIGHT in North Carolina.
October/November 2007 Vol. 9, Issue 20 visit IDCR online at www.IDCRonline.org
